Evolutionary biologist, turned CEO for Beacon: for rare diseases. All views my own.

Cambridge, UK
Joined January 2015
Rick Thompson retweeted
We’ve compiled a series of case studies to demystify the #DrugRepurposing process. Our latest case features Nitroxoline, a common antibiotic repurposed for rare amoebic encephalitis—led by #iDR25 speaker Natasha Spottiswoode. ➡️ More here: loom.ly/g4avr9o
1
1
3
75
And just like that, #OpenAcademy2024 is complete! 🎉 Our thanks go to everyone who has made this experience possible and our amazing group of participants for throwing themselves into the training so wholeheartedly! Learn more about #EURORDISOpenAcademy:  openacademy.eurordis.org
2
2
23
1,539
It was an absolute privilege to be part of the team organising and delivering #iDR24. Thanks to all the attendees, and my amazing colleagues in @RareBeacon and @REMEDi4ALL! See you next year!
🌟Thanks for joining us at the #iDR24 International #DrugRepurposing Conference in Barcelona. We look forward to our next opportunity to meet, discuss the many challenges, bust myths, share best practices & further work towards a better future for patients. Safe journey home.
1
9
233
Not only are we co-organisers and pathway hosts for #iDR24 - we’re also exhibiting and displaying a poster, co-authored with our friends at @eurordis! Make sure to find us during the breaks and pick up one of our coveted Beacon swag bags! 🔥
3
12
441
Rick Thompson retweeted
Wow - what a great day innovating, connecting & reshaping the #DrugRepurposing ecosystem! We'd love to hear your takeaways from the day. 📣And it's not over yet...the #iDR24 poster presentations are about to take place!
1
2
12
464
Rick Thompson retweeted
⚡The air is electric here on Day 1 at #iDR24! Together with over 50 speakers from across a broad range of disciplines we will deep-dive into the evolving landscape of #DrugRepurposing. ➡️Find out more here: remedi4all.org/international…
4
2
18
1,054
I’ve been writing about the VITAL role of #patients in #RareDisease research this #RareDiseaseDay2024 - how do you see patients driving research change?
This quoted post is unavailable.
2
52
Panel discussion time!
2
119
Prof Alfredo Budillon introduces the VESPA trial - one of the demonstrator projects within ⁦@REMEDi4ALL⁩ looking to repurpose drugs for pancreatic cancer.
1
3
144
Dr Luca Cardone says repurposing is a mandatory strategy for #PancreaticCancer research the the ⁦@REMEDi4ALL⁩ Multistakeholder meeting.
3
91
Ali Stunt, founder of ⁦@OfficialPCA⁩ Pancreatic Cancer Action in the UK, talks about her personal pancreatic cancer story and the need for improved outcomes for patients.
3
73
Patrycja shares her personal story as a pancreatic cancer survivor - investigative tests found a tumour in her abdomen at the age of 25.
3
80
Don Lo from ⁦@REMEDi4ALL⁩ makes the case for repurposing - why find every possible new drug out there before we have made the BEST use of the drugs we already have?
1
6
308
Gauthier Bouche from the ⁦@Anticancerfund⁩ takes us into the world of repurposing at the ⁦@REMEDi4ALL⁩ multistakeholder meeting.
6
92
We’re off! Prof Alfredo Carrara gives the opening talk for the first ⁦⁦@REMEDi4ALL⁩ multistakeholder meeting. We’re talking pancreatic cancer and repurposing.
1
5
249
Really happy to be at the ⁦@AMRC⁩ festival of partnerships today. Learning a lot, and highlighting our work for #rarediseases at ⁦@RareBeacon⁩
2
70
Rick Thompson retweeted
@REMEDi4ALL, patients are equal partners in research. 🔬 Rick Thompson (@RickSThomp), CEO @RareBeacon and project partner shares his views on why #patientengagement matters so much. 👉 Find out more about @REMEDi4ALL here: remedi4all.org
1
1
5
140
Ready to kick off the 1st ⁦@REMEDi4ALL⁩ Sustainability meeting! Feeling strategic?
1
10
387
Do you want to work with us? 🙋 With openings across all three of our European offices, we are looking for talented and passionate individuals to join the EURORDIS team. If you believe in our vision and mission then we want to hear from you! 🔗 go.eurordis.org/wvv7f7
5
1
21
1,605